龙虎榜数据显示，该股因连续3个交易日内日收盘价格涨幅偏离值累计达30%、日收盘价涨幅达15%上 榜龙虎榜1次，买卖居前营业部中，机构净买入2042.68万元，深股通累计净卖出1787.04万元，营业部席 位合计净卖出6698.22万元。 据天眼查APP显示，迪安诊断技术集团股份有限公司成立于2001年09月05日，注册资本62497.9436万人 民币。（数据宝） 迪安诊断盘中涨停，已连收3个涨停板，截至9:25，该股报31.27元，换手率1.45%，成交量728.47万股， 成交金额2.28亿元，涨停板封单金额为5.97亿元。连续涨停期间，该股累计上涨72.76%，累计换手率为 32.89%。最新A股总市值达195.43亿元，A股流通市值156.81亿元。 证券时报·数据宝统计，两融数据来看，该股最新（1月12日）两融余额为7.69亿元，其中，融资余额 7.66亿元，较前一个交易日增加7655.15万元，环比增长11.11%，近3日累计增加1.11亿元，环比增长 16.92%。 （文章来源：证券时报网） 近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | -- ...

格隆汇1月13日｜A股开盘，三大指数集体高开，沪指高开0.11%报4169.7点，深证成指涨0.21%，创业 板指涨0.07%。盘面上，AI应用概念股涨势延续，易点天下、通达海、迪安诊断(300244)20CM涨停；军 工装备板块调整。 ...

Group 1 - The A-share market's AI application sector continues to perform strongly, with companies like Di'an Diagnostics, Yidian Tianxia, and Tianlong Group hitting the 20% daily limit up, marking a three-day consecutive rise [1] - The AGI-Next summit initiated by Tsinghua University's key laboratory highlights a shift in large model competition from "Chat" to "Agent," focusing on executing complex tasks in real environments [1] - The acceleration of AI applications in the healthcare sector is notable, with Ant Group's "Antifufu" transforming into an AI health partner and quickly entering the top 3 of the Apple App Store, indicating strong consumer demand for integrated healthcare services [1] Group 2 - Citic Construction Investment Securities emphasizes that as model capabilities improve and costs for reasoning and long-window tasks decrease, AI downstream application scenarios are rapidly entering the commercialization verification phase, particularly in search & marketing, coding, multimodal, Agent, and AI for Science fields [2] - The stock performance of key companies in the AI sector shows significant year-to-date gains, with Yidian Tianxia up 87.36%, Di'an Diagnostics up 97.29%, and Tianlong Group up 82.26% [3]

Group 1 - The core viewpoint of the article highlights the significant rise in the stock price of Dean Diagnostics, which has achieved a three-day consecutive limit-up, indicating strong market interest in AI applications in the healthcare and pharmaceutical sectors [1] - Dean Diagnostics' stock reached a limit-up at 9:35 AM with a trading volume of 1.197 billion yuan and a turnover rate of 7.64%, reflecting high investor activity [1] - The recent surge in the AI healthcare and pharmaceutical sector is attributed to technological breakthroughs that have increased market attention on the application value of AI in these fields [1] Group 2 - The company is actively advancing its technological innovations and market expansion in precision medicine, which has garnered significant industry attention [1]

Group 1 - The AI medical concept is experiencing significant activity, with companies like Dean Diagnostics and Hongbo Pharmaceutical hitting the 20% daily limit increase [1] - Meian Health has achieved a three-day consecutive increase, indicating strong market interest [1] - Other companies such as Jiahe Meikang and Chengdu Xian Dao have seen increases of over 10%, while Anbiping, Weining Health, Yaoshi Technology, and Guoxin Health are also following the upward trend [1]

（编辑 姚尧） 证券日报网讯 1月12日，迪安诊断发布公告称，迪安诊断技术集团股份有限公司股票连续三个交易日内 （2026年1月8日、1月9日、1月12日）收盘价格涨幅偏离值累计达到30%以上，属于股票交易异常波动 情形。公司前期披露的信息不存在需要更正、补充之处；公司未发现近期公共传媒报道了可能或已经对 公司股票交易价格产生较大影响的未公开重大信息。 ...

Group 1 - The core index of the biotechnology sector, the Biotechnology Index (970038), closed at 2297.26 points, reflecting a 1.74% increase with a trading volume of 34.699 billion yuan and a turnover rate of 2.6% [1] - Among the constituent stocks of the Biotechnology Index, 35 stocks experienced an increase, with Dean Diagnostics leading the rise at 19.98%, while 14 stocks saw a decline, with New Industry leading the drop at 3.84% [1] Group 2 - In terms of capital flow, the Biotechnology Index constituents experienced a net outflow of 190 million yuan from major funds, while retail investors saw a net inflow of 286 million yuan [2] - The detailed capital flow indicates that speculative funds had a net outflow of approximately 95.6729 million yuan [2]

Market Overview - The market showed strong fluctuations throughout the day, with all three major indices rising over 1%, and the Shanghai Composite Index achieving a 17-day consecutive rise [1] - AI application sectors experienced a significant surge, with stocks like BlueFocus and Hand Information hitting the daily limit [1] - The commercial aerospace concept continued its strong performance, with China Satellite and China Satcom both reaching new highs [1] - The brain-computer interface concept was also active, with stocks like DaoTech and Yanshan Technology hitting the daily limit [1] - Over 4,100 stocks in the Shanghai, Shenzhen, and Beijing markets rose, with a total transaction volume of 3.64 trillion, setting a new record for daily trading in A-shares [1] AI Marketing - The AI marketing concept saw a wave of limit-up stocks, including Gravity Media, Leo Holdings, and BoRui Communication [4] - Elon Musk announced on social media that he would open-source the latest content recommendation algorithm for the X platform within a week, interpreted by the market as his entry into the GEO space [4] - DeepSeek is set to release its next-generation flagship AI model, DeepSeek V4, in February, which reportedly outperforms major models like Anthropic Claude and OpenAI GPT series in programming capabilities [4][7] - Anthropic's Claude Code received a significant update, marking a new phase in global AI programming competition [4] Aerospace Sector - The aerospace sector continued to rise, with stocks like Luxin Investment, Goldwind Technology, and Daye Shares hitting the daily limit [10] - China applied for frequency resources for over 200,000 satellites, indicating a strategic national-level initiative [11] - Experts believe that the establishment of the Radio Innovation Institute will accelerate the 6G process, integrating satellite networks with ground communication networks [14] AI Medical - The AI medical sector also performed well, with companies like Meinian Health and Dean Diagnostics seeing consecutive gains [15] - OpenAI launched "ChatGPT Health," a health-related dialogue space that connects electronic medical records and health applications [15] - The demand for AI in healthcare is expected to grow significantly, driven by an aging population and an increase in chronic disease patients [18]

证券之星消息，1月12日医疗服务板块较上一交易日上涨1.96%，迪安诊断领涨。当日上证指数报收于 4165.29，上涨1.09%。深证成指报收于14366.91，上涨1.75%。医疗服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | --- | | 300244 | 迪安诊断 | 26.06 | 19.98% | | 53.35万 | | 13.76亿 | | 920670 | 数字人 | 21.21 | 16.03% | | 17.81万 | | 3.59亿 | | 300149 | 睿智医药 | 12.61 | 15.16% | | 81.36万 | | 10.15 乙 | | 688796 | 百奥赛图 | 68.68 | 14.87% | | 6.44万 | | 4.25亿 | | 301230 | 泓博医药 | 47.30 | 14.69% | | 32.66万 | | 15.01亿 | | 688222 | 成都先导 | 37.00 | 13.7 ...

证券代码：300244 证券简称：迪安诊断 公告编号：2026-003 迪安诊断技术集团股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 迪安诊断技术集团股份有限公司（以下简称"公司"或"迪安诊断"）股票连 续三个交易日内（2026年1月8日、1月9日、1月12日）收盘价格涨幅偏离值累计达到 30%以上，根据《深圳证券交易所交易规则》的有关规定，属于股票交易异常波动情 形。 二、公司关注并核实相关情况 5. 公司控股股东、实际控制人、董事和高级管理人员在股票异常波动期间不存 在买卖公司股票的情形。 三、是否存在应披露而未披露信息的说明 公司董事会确认，公司目前没有任何根据《深圳证券交易所创业板股票上市规 则》等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、 协议等；董事会也未获悉本公司有根据《深圳证券交易所创业板股票上市规则》等 有关规定应予以披露而未披露的、对本公司股票及其衍生品种交易价格产生较大影 响的信息；公司前期披露的信息不存在需要更正、补充之处。 四、风险提示 1. ...